News & Events

Johannes R. Kratz, M.D. and Yeranuí Ledesma, M.D. are among this year's recipients of the 2017 UCSF Health Exceptional Physician Award. Dr. Kratz, now a member of the Thoracic Oncology Program and Assistant Professor in the Division of Adult Cardiothoracic Surgery, and Dr. Ledesma, a Senior Resident in General Surgery, were among 8 winners out of 61 nominees, notably the only clinical fellow and resident, respectively, at UCSF to receive the award, and the only recipients not on the faculty.  The official announcement reads: We are delighted to announce the 2017 UCSF Health Exceptional [...]

The 28th Annual J. Engelbert Dunphy Resident Research Symposium was held on March 11, 2015 at Toland Hall. Jennifer Grandis, MD,  Associate Vice Chancellor of Clinical and Translational Research, Director of Clincial and Translational Science Institute, and Professor of Otolaryngology-Head & Neck Surgery, gave the keynote presentation.  Left to right: Bian Wu, Carlie Thompson, Peter Stock, Gavitt Woodard, Jennifer Grandis, Nancy Ascher, Jessica Cohan, Lily Cheng, Benjamin Howard 2015 Presentation Winners Best Basic Science Presentation Gavitt Woodard, M.D. Best [...]

Building on earlier retrospective validation studies, a team of Thoracic Oncology Program researchers, demonstrated in a small prospective study the clinical utility of a 14-gene expression assay in stratifying risk among non-small cell lung cancer (NSCLC) patients. In a recently published paper in the journal Clinical Lung Cancer, lead author Gavitt Woodard, M.D., a general surgery research resident in the Thoracic Oncology Laboratory, and coauthors  David M. Jablons, M.D. (pictured second) and Michael Mann, M.D., (pictured 3rd) began  to address a key question regarding widespread use of [...]

The Mesothelioma Applied   Research Foundation (MARF), a leading national funder of research for this disease, has awarded Il-Jin Kim, Ph.D.,  Assistant Professor and  Director of Applied Genomics in the  Thoracic Oncology Laboratory, a grant to study Novel fusion and tumor-specific isoform candidates in malignant pleural mesothelioma (MPM), an aggressive and highly lethal cancer, with the ultimate goal of identifying therapeutic targets. The research focuses on a class of patient who lack the three most common genetic deletions (CDKN2A, NF2, and BAP1). Studying the unique genetic profile of [...]

Building on their  earlier work reported in The Lancet, two UCSF thoracic surgeons   David M. Jablons, M.D. (left) and   Michael Mann, M.D. (middle), and  Johannes Kratz, M.D. (right) a former surgical resident in the  Thoracic Oncology Lab, showed they could accurately stratify patients even with the earliest stage of lung cancer into groups at low-, intermediate- or high-risk of death based solely on the activity of 14 different genes found in their tumors. The group analyzed lung  tumors of patients diagnosed as Stage 1A  (T1a node-negative non-small-cell lung cancers (NSCLC)), the [...]

The NIH has awarded two UCF scientists, Hassan Lemjabbar-Alaoui, Ph.D and Joanna J. Phillips, M.D., Ph.D., a five-year $2.2m grant to study the clinical utility of extracellular heparan sulfate endosulfatases, or SULFs, as biomarkers for early detection of non-small cell lung cancer (NSCLC) and malignant astrocytoma. Lung cancer is the leading cause of cancer death in the U.S. and world-wide. Astrocytomas are primary brain neoplasms (tumors). Glioblastoma multiforme (GBM), the most common and malignant primary brain tumor, was responsible for the death of the late Senator Edward M. Kennedy. [...]

In the two largest clinical studies ever conducted on the molecular genetics of lung cancer, an international team, led by UCSF thoracic surgeons David M. Jablons, M.D. and Michael Mann, M.D., demonstrated that a 14-gene prognostic molecular assay better predicted the likelihood of death in early-stage lung cancer  patients versus conventional staging guidelines. Johannes Kratz, M.D., a former surgical resident in the  Thoracic Oncology Laboratory, helped spearhead the  development of the assay and was lead author of a paper published in The Lancet discussing the results. John Minna, M.D.", [...]

A team consisting of Hassan Lemjabbar-Alaoui, Ph.D.,  Assistant Adjunct Professor of Surgery and principal Investigator in the Thoracic Oncology Laboratory and Alaoui Lab, and Steven Rosen, PhD, Professor and Vice-chair of the Department of Anatomy, are developing a novel treatment for lung cancer in a unique collaboration between UCSF and Pfizer, the world's largest drug company. The Rosen-Alaoui team has identified an enzyme found at high levels in lung and other cancers and is developing antibodies to target the enzyme and disable the cancer, even in cells rendered cancerous by cigarette [...]

On October 16th, the Porsche Race Car Classic was held at at the Quail Lodge in Napa, CA.  The event, a collaboration with Porsche AG and Porsche Cars North America, was hosted by the UCSF Thoracic Oncology Program and Bonnie J. Addario Lung Cancer Foundation. Proceeds from the highly successful event benefited the respective hosts. The theme, "Driving Lung Cancer Off the Planet", was underscored in a video produced by the Thoracic Oncology Program in connection with the event. Narrated by David M. Jablons, M.D., FACS, [...]

  The UCSF Thoracic Oncology Laboratory recently acquired the 5500 Series SOLiDTM , a next-generation DNA sequencer manufactured by Life Technologies Inc. This state-of-the-art sequencer offers a level of precision  previously unattainable, and empowers lab scientists to more deeply probe the underlying molecular biology of myriad cancers: from primary thoracic tumors such as lung cancer, esophageal cancer, and mesothelioma, to metastatic sarcoma, melanoma, colorectal cancer, and breast cancer that has spread to the lung.Insights gained from  this research could lead to [...]

David M. Jablons, M.D., FACS, Professor and Chief of General Thoracic Surgery and Program Leader of the Thoracic Oncology Program, was recently inducted into into the American Surgical Society. The American Surgical Association was founded in 1880 and describes itself as the nation's oldest and most prestigious surgical organization. Among its members are the nation's most prominent surgeons from leading academic medical institutions, many of whom are Department of Surgery Chairs. Membership also includes leading surgeons from around the world.

Researchers reported in the New England Journal of Medicine that screening smokers and former smokers with spiral CT scans reduced  lung cancer deaths by 20%, reaffirming earlier findings in the NLST screening trial. David M. Jablons, M.D., Professor and Chief of Thoracic Surgery and Program Leader of the Thoracic Oncology Program noted the study's significance: "This is a landmark study and a landmark day for millions of people at risk for lung cancer. This study vindicates numerous pioneering investigators worldwide who have advocated for the utility and benefit of low-dose spiral CT scans [...]

The UCSF Thoracic Oncology Laboratory, led by David Jablons, M.D., Professor and Chief of Thoracic Surgery and Program Leader of Thoracic Oncology, recently launched its first Lung Cancer Joint Laboratory in China, an alliance with Guangzhou Institute of Respiratory Disease (China National Key Laboratory of Respiratory Disease) and the First Affiliated Hospital of Guangzhou Medical College. A signing ceremony was held in Guangzhou, China.

Last October, opera singer Zheng Cao fell during a performance and had no idea why.  Later, it turned out she had advanced lung cancer. Now, as a result of treatment with a new type of targeted therapy, her cancer is retreating. Personalized medicine - that is, customizing the treatment to the patient's tumor -is rapidly gaining ground in the treatment of lung cancer.This has given hope to patients like Zheng Cao that their lung cancer can be successfully treated.

The Bonnie J. and Anthony Addario Endowed Chair in Thoracic Oncology has been created in the Department of Surgery in honor of Thierry Jahan, M.D., an Associate Professor of Medicine at UCSF, who will occupy the Chair as its first recipient. Dr. Jahan is the one of the region's most highly regarded thoracic oncologists and sarcoma specialists, known among patients, their families, and colleagues for his deep sense of empathy and compassion. Dr. Jahan  co-founded the multidisciplinary Thoracic Oncology Program with David Jablons M.D.. On July 9, 2009, there was a celebration held at the [...]

Dr. David Jablons, Chief of the Thoracic Section, is co-chairing the 13th World Conference on Lung Cancer, July 31 - August 4, 2009.  The meeting will be held at the Moscone West in San Francisco. 

"To find answers, Mrs. Addario and her husband, along with David M. Jablons, her surgeon from the University of California, San Francisco, put together a two-day conference last fall of lung cancer researchers from major institutions around the world. She says the group identified a number of problems that hinder progress toward a cure. Among them: Researchers didn't know what others were doing, tissue and blood specimens needed for experiments weren't centrally located or shared, and the findings of experiments weren't integrated to help assess what the key priorities should be. Mrs. Addario [...]

SFGate (San Francisco Chronicle Online) reports on lung cancer survivor Bonnie J. Addario and her inspiration to start an organization, The Bonnie J. Addario Lung Cancer Foundation, to make  strides in the fight against lung cancer.  Addario received the Jefferson Award for her work. Bonnie J. Addario broke barriers by becoming one of the country's top female oil company executives. Now, she is parlaying her professional prowess into running one of the country's largest lung-cancer foundations Twenty-two years ago, with just a high school education, Addario started out as a secretary and [...]

Adding their own contributions to a rapidly advancing field, UCSF researchers - along with colleagues from Incyte Corporation and the University of Texas Southwestern Medical Center - have described new targets in lung cancer and evaluated a promising new drug candidate that halts growth signals in tumor cells grown in the lab. Their report is featured in the July issue of the scientific journal Cancer Cell. 

SFGate.com reports on the collaboration of David M. Jablons, M.D. and Jeff Peterson whose wife Karen and died from mesothelioma, a devastating disease. Dr. David Jablons couldn't save Karen Peterson's life or even extend it. But he could give quality to whatever life she had left. That turned out to be about nine months, long enough for her twin boys to see her waterskiing on Lake Tahoe and boogie-boarding in Oceanside and laughing more than coughing.  Jablons, chief cardiothoracic surgeon at UCSF, was the last in a line of specialists Peterson had sought out coast to coast in a 22-month [...]